Clinical Trial Update: Prognostic Value of Respiratory System Compliance Under VV-ECMO on 180-day Mortality in COVID-19 ARDS.

View source ↗

Summary

A completed clinical trial examined whether respiratory system compliance during VV-ECMO predicts 180-day mortality in patients with COVID-19–related ARDS.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome

Snippet

Sponsor: Central Hospital, Nancy, France | Conditions: Ards, Mechanical Ventilation Pressure High | Status: COMPLETED